Market Overview:
The global autoimmunity reagents market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of autoimmune diseases, rising demand for early diagnosis and treatment of autoimmune diseases, and technological advancements in autoimmunity reagents. Based on type, the global autoimmunity reagents market is segmented into blotting assays, ELISA assays, IFA assays, and CLIA assays. The blotting assay segment is expected to grow at the highest CAGR during the forecast period owing to its ability to detect minute amounts of proteins in a sample. Based on application, the global autoimmunity reagents market is segmented into hospitals and third-party testing agencies.
Product Definition:
Autoimmune reagents are used to detect and measure autoantibodies in serum or plasma. Autoantibodies are antibodies that target self-proteins, and their presence is indicative of autoimmune disease. Measuring the levels of autoantibodies can help clinicians to diagnose autoimmune diseases, monitor disease progression, and assess the effectiveness of treatments.
BLOT:
BLOT or Bacterial lawn on Laminar Airflow Technology is a technique used for the separation of proteins based on their molecular weight. It helps in the detection of cross-reactivity between antigens present in different species. The method also helps to identify new protein allergens and determine their role in disease pathogenesis.
The global BLOT market size was valued at USD 89,25000 in 2016.
ELISA:
ELISA (enzyme-linked immunosorbent assay) is a widely used enzyme immunoassay technique for the detection of autoantibodies. It is also used in research settings to study autoimmune diseases and other immune system-related disorders. The ELISA reagents market has been witnessing significant growth over the past few years owing to its increasing application in research settings as well as rising demand from clinical laboratories across the globe.
Application Insights:
The hospital application segment accounted for the largest revenue share in 2017. Autoimmune diseases are a major concern in hospitals as they lead to significant loss of life and suffering of patients. To avoid such situations, auto-immune disease testing is carried out at regular intervals in most hospitals worldwide. Hence, an increasing number of autoimmune disease cases is expected to fuel the demand for autoimmunity reagents over the forecast period.
The third-party testing agency segment is anticipated to witness lucrative growth over the forecast period owing to factors such as rising awareness about diseases and their symptoms among individuals who have been diagnosed but not yet started treatment, or have completed it but still need monitoring by doctors or researchers involved with clinical trials related to these disorders.
Regional Analysis:
North America dominated the global autoimmunity reagents market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for technologically advanced products are some of the factors responsible for its large share. Moreover, increasing prevalence of chronic diseases such as multiple sclerosis (MS) and rheumatoid arthritis (RA) is expected to drive the demand for autoantibodies testing in North America over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with growing awareness about early diagnosis among patients. Increasing investments by major market players in this region towards expansion strategy includes new product launches, partnerships & acquisitions are also contributing toward regional growth. For instance; In January 2016; Abbott launched a new diagnostic test called Autoimmune Monitoring Test (AMT).
Growth Factors:
- Increasing incidence of autoimmune diseases: The global incidence of autoimmune diseases is increasing at a significant rate. This is primarily attributed to the changing lifestyle and environmental factors. This is expected to drive the demand for autoimmunity reagents over the forecast period.
- Growing awareness about autoimmune diseases: There is a growing awareness among people about autoimmune diseases and their symptoms. This has led to an increase in the number of people seeking diagnosis and treatment for these conditions, thereby driving the demand for autoimmunity reagents market globally.
- Technological advancements in diagnostics: The technological advancements in diagnostics are aiding in early diagnosis of autoimmune diseases, which is further propelling the growth of autoimmunity reagents market globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Autoimmunity Reagents Market Research Report
By Type
BLOT, ELISA, IFA, CLIA
By Application
Hospital, Third-Party Testing Agency
By Companies
EUROIMMUN, HUMAN, Bio-Rad Laboratories, AESKU, Inova, MBL, Orgentec, Trinity, Phadia, HOB Biotech, Shenzhen YHLO Biotech, Kangrun Biotech, Immuno-Biological Laboratories, Biomedical diagnostics, Shanghai Kexin
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
166
Number of Tables & Figures
117
Customization Available
Yes, the report can be customized as per your need.
Global Autoimmunity Reagents Market Report Segments:
The global Autoimmunity Reagents market is segmented on the basis of:
Types
BLOT, ELISA, IFA, CLIA
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Third-Party Testing Agency
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EUROIMMUN
- HUMAN
- Bio-Rad Laboratories
- AESKU
- Inova
- MBL
- Orgentec
- Trinity
- Phadia
- HOB Biotech
- Shenzhen YHLO Biotech
- Kangrun Biotech
- Immuno-Biological Laboratories
- Biomedical diagnostics
- Shanghai Kexin
Highlights of The Autoimmunity Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BLOT
- ELISA
- IFA
- CLIA
- By Application:
- Hospital
- Third-Party Testing Agency
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autoimmunity Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autoimmunity Reagents is a company that manufactures and sells antibodies for research and diagnostic purposes.
Some of the major players in the autoimmunity reagents market are EUROIMMUN, HUMAN, Bio-Rad Laboratories, AESKU, Inova, MBL, Orgentec, Trinity, Phadia, HOB Biotech, Shenzhen YHLO Biotech, Kangrun Biotech, Immuno-Biological Laboratories, Biomedical diagnostics, Shanghai Kexin.
The autoimmunity reagents market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autoimmunity Reagents Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autoimmunity Reagents Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autoimmunity Reagents Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autoimmunity Reagents Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autoimmunity Reagents Market Size & Forecast, 2020-2028
4.5.1 Autoimmunity Reagents Market Size and Y-o-Y Growth
4.5.2 Autoimmunity Reagents Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 BLOT
5.2.2 ELISA
5.2.3 IFA
5.2.4 CLIA
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Third-Party Testing Agency
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autoimmunity Reagents Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autoimmunity Reagents Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 BLOT
9.6.2 ELISA
9.6.3 IFA
9.6.4 CLIA
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Third-Party Testing Agency
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 BLOT
10.6.2 ELISA
10.6.3 IFA
10.6.4 CLIA
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Third-Party Testing Agency
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 BLOT
11.6.2 ELISA
11.6.3 IFA
11.6.4 CLIA
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Third-Party Testing Agency
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 BLOT
12.6.2 ELISA
12.6.3 IFA
12.6.4 CLIA
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Third-Party Testing Agency
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 BLOT
13.6.2 ELISA
13.6.3 IFA
13.6.4 CLIA
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Third-Party Testing Agency
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autoimmunity Reagents Market: Competitive Dashboard
14.2 Global Autoimmunity Reagents Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EUROIMMUN
14.3.2 HUMAN
14.3.3 Bio-Rad Laboratories
14.3.4 AESKU
14.3.5 Inova
14.3.6 MBL
14.3.7 Orgentec
14.3.8 Trinity
14.3.9 Phadia
14.3.10 HOB Biotech
14.3.11 Shenzhen YHLO Biotech
14.3.12 Kangrun Biotech
14.3.13 Immuno-Biological Laboratories
14.3.14 Biomedical diagnostics
14.3.15 Shanghai Kexin
